BillionToOne (BLLN) vs Oscar Health (OSCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Oscar Health is the larger company by market cap ($10.22 billion vs $4.50 billion), about 2.3 times the size, while BillionToOne is growing revenue faster (+100.0% vs +27.5%). On valuation, Oscar Health trades at a lower forward P/E (15.3x vs 64.2x for BillionToOne). BillionToOne converts more of its revenue into profit, with a net margin of 2.4% versus -3.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLLN | OSCR |
|---|---|---|
| Share price | $95.41 | $33.10 |
| Market cap | $4.50B | $10.22B |
| 1-day change | -0.36% | +0.58% |
| YTD return | +16.58% | +130.34% |
| 1-year return | — | +51.83% |
| 5-year return | — | +108.83% |
| P/E ratio (TTM) | 151.44 | 25.66 |
| Forward P/E | 64.25 | 15.29 |
| EPS (TTM) | $0.63 | $1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $305.11M | $11.70B |
| Revenue growth (YoY) | +99.97% | +27.50% |
| Net income (latest FY) | $7.45M | $-443.15M |
| Gross margin | 68.32% | — |
| Operating margin | 5.25% | -3.39% |
| Net margin | 2.44% | -3.79% |
| 52-week high | $150.44 | $34.48 |
| 52-week low | $61.96 | $10.69 |
| Distance from 52-week high | -36.58% | -4.00% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +35.21% | +6.95% |
| Average volume | 689.14K | 5.20M |
| Shares outstanding | 42.64M | 273.47M |
| Employees | 713 | 2,305 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Oscar Health is about 2.3 times larger than BillionToOne by market value ($10.22B vs $4.50B).
- BillionToOne trades at a higher earnings multiple (151.4x vs 25.7x trailing P/E).
- BillionToOne is more profitable, keeping 2.4 cents of every revenue dollar as net income versus -3.8 cents for Oscar Health.
- BillionToOne grew revenue faster in its latest fiscal year (+99.97% vs +27.50%).
About BillionToOne
BLLN stock →BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
Health Care · Medical Specialities · 713 employees
About Oscar Health
OSCR stock →Oscar Health, Inc. operates as a healthcare technology company in the United States.
Health Care · Medical Specialities · 2,305 employees
BLLN vs OSCR FAQ
Which is bigger, BillionToOne or Oscar Health?
Oscar Health (OSCR) is larger, with a market capitalization of $10.22B compared with $4.50B for BillionToOne (BLLN).
Which has the lower P/E ratio, BLLN or OSCR?
OSCR has the lower trailing P/E at 25.7, versus 151.4 for BLLN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are BillionToOne and Oscar Health in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.